Vanguard Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$470M Buy
2,442,741
+31,570
+1% +$5.13M 0.01% 698
2026
Q2
$329M Buy
2,411,171
+14,660
+0.6% +$1.8M 0.01% 873
2026
Q1
$282M Hold
2,396,511
– – 0.01% 882

Other funds holding RGEN

Vanguard Capital Management's RGEN Position: Q3 2026 in Review

Vanguard Capital Management increased its Repligen (RGEN) stake by 1.3% in Q3 2026, buying an estimated $5.13M and bringing the position to 2,442,741 shares worth $470M. The position accounts for 0.01% of the portfolio, ranked #698.

Vanguard Capital Management first reported a position in RGEN in Q1 2026 and has held it in 3 quarters since. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Vanguard Capital Management held 2,442,741 shares of Repligen worth $470M as of Q3 2026.
  • Vanguard Capital Management bought 31,570 Repligen shares in Q3 2026, an estimated $5.13M.
  • Repligen made up 0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #698 holding.
  • Vanguard Capital Management first reported a position in Repligen in Q1 2026 and has held it in 3 quarters since.
  • 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.